Hyperspectral Retinal Observations for the Cross-sectional Detection of Alzheimer's Disease

Two devices will be tested in this research:Mantis Photonics' hyperspectral camera for non-invasive retinal examination (i.e., a hardware medical device under investigation).Blekinge CoGNIT cognitive ability test (i.e., an assessment).

Inclusion Criteria:subject age over 18 years oldThe subject has undergone a lumbar puncture an cerebrospinal fluid analysis as part of the standard care.The subject has at least one healthy eye.The subject is applicable for taking a blood sample for the blood analysis test.The informed consent is provided, explained and understood by the person. The person has consented to the informed consent.Exclusion Criteria:There are contra-indications for lumbar puncture (eg: brain tumor with suspicion of raised intracranial pressure, coagulopathies or ongoing anticoagulant medications) will be excluded from the study.When the subject suffers from excessive visual or auditive impairment, the he/she will be excluded from the CoGNIT track.